Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Aqueous Release to Treat IOP Spikes Post-cataract Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03500809
Recruitment Status : Unknown
Verified July 2018 by Anant Sharma, Bedford Hospital NHS Trust.
Recruitment status was:  Not yet recruiting
First Posted : April 18, 2018
Last Update Posted : July 27, 2018
Sponsor:
Information provided by (Responsible Party):
Anant Sharma, Bedford Hospital NHS Trust

Brief Summary:

Intraocular pressure (IOP) rise after cataract surgery is an important and common problem. Over 300,000 cataract operations are done per year in the United Kingdom alone. IOP rise can adversely affect vision and can be particularly detrimental in glaucoma patients with pre-existing visual field defects. The aim of this study is to evaluate the efficacy and safety of aqueous humor release (also known as burping of the wound), a procedure that has been used for decades to quickly reduce acute IOP spikes following cataract surgery.

Currently there is no published evidence on a standard technique to perform wound burping. Similarly there is uncertainty around the amount and duration of the IOP decrease, and the type and frequency of complications eventually associated. This will be the first research project formally evaluating this procedure. This study will also help allay issues over fluid release in high IOPs and consequences of such dramatic IOP drop which concerns ophthalmologists who do not routinely use this technique.


Condition or disease Intervention/treatment Phase
Post-Op Complication Raised Ocular Pressure Procedure: Aqueous release of the wound Not Applicable

Detailed Description:

At present there is no de facto standard to manage acute intraocular pressure (IOP) rise following cataract surgery. Several drugs, both topical and systemic, have been tested for their ability to blunt the acute IOP spike, nevertheless none has proven to be superior and consistently effective. Oral acetazolamide has demonstrated to help controlling IOP spikes following cataract surgery in glaucomatous eyes. However there are still constraints in its widespread use, as it may be contraindicated in patients with poor renal function, sickle cell disease and sulpha drug allergy.

As a result, many units including Moorfields Eye Hospital have used a technique called known as 'burping of the corneal wound' to release fluid from inside the anterior chamber of the eye. This makes logical sense as it reduces the pressure immediately and may remove some of the causes for raised IOP such as retained viscoelastic and inflammatory molecules from inside the eye. This technique has also been used to reduce IOP in patients already receiving pharmaceutical treatment.

The technique has been used for decades, however, there is no published evidence of a proposed technique, range of IOP decrease or frequency of complications. Thus, most surgeons in most units are cautious of 'burping the wound' as it may induce infection or other complications compromising the surgical outcome due to the sudden reduced IOP reduction. Nevertheless a similar approach, needle penetrating the eye to release aqueous and reduce IOP, is becoming more popular as the first approach to treat an acute angle closure crisis, where the presenting IOP is often very high, i.e. a much more difficult and dangerous situation than post cataract surgery.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 20 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Efficacy and Safety of Aqueous Humour Release (Burping) Performed at the Slit-lamp to Treat Acute Intraocular Pressure (IOP) Spikes Post-cataract Surgery
Estimated Study Start Date : August 12, 2018
Estimated Primary Completion Date : January 12, 2019
Estimated Study Completion Date : July 12, 2019

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Aqueous release (Burping) of the wound

Following uneventful cataract surgery, wound "burping" will be performed in all eligible patients who gave their informed consent. The procedure will be offered whenever the intraocular pressure (IOP) is either higher than 30 mmHg or deemed inappropriate in view of the ocular condition (e.g. glaucoma).

After 'burping' the wound, patients will have their IOP measured using Goldmann application tonometry (GAT) immediately and at 2 hours. The 'burping' procedure will be repeated until satisfactory pressure is achieved and care will be taken to avoid shallowing of the anterior chamber while fluid is released. We will assess for the presence of leaks from the wound with a Seidel test with fluorescein 5% once the IOP is satisfactory. To prevent any infection after each procedure, we will prescribe post-op drops including chloramphenicol 0.5% four times a day for 2 weeks or minimum of 3 days and these will continue as per routine. All other complications will be recorded at follow-up.

Procedure: Aqueous release of the wound
  1. Anaesthetic drop (tetracaine 1%) followed by povidone iodine 5% drop is instilled. After 5 minutes, a sterile 30 gauge needle tip is pressed on the posterior lip of the one of the existing cuts (paracentesis or main wound) from cataract surgery to release the fluid and consequently the pressure.
  2. This will be performed under careful monitoring to avoid any undesirable shallowing of the anterior chamber of the eye.
Other Name: 'Burping' procedure




Primary Outcome Measures :
  1. Efficacy of 'burping' the wound to reduce IOP (mmHg) post-cataract surgery when measured using Goldmann application tonometry (GAT) [ Time Frame: 6 months ]
    Reduction in IOP (mmHg) post-cataract surgery after the 'burping' procedure


Secondary Outcome Measures :
  1. Range of IOP decrease (mmHg) [ Time Frame: 6 months ]
    To observe and record the range of IOP decrease (mmHg) from individual 'burping' procedures

  2. Frequency of complications post-'burping' procedure [ Time Frame: 6 months ]
    Observing the frequency of complications, including but not limited to, severe pain, worsening of vision, or infection



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 90 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patient whose post-operative IOP was regarded to be too high for visual safety, or higher than 30mmHg, on the same day or within 1 week of the surgery

Exclusion Criteria:

  • Patients with IOP less than 30 mmHg or IOP deemed by clinician not too high to treat
  • Patients unable to cooperate
  • Patients who have undergone complicated cataract surgery

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03500809


Contacts
Layout table for location contacts
Contact: Anant Sharma, MBBS, FRCOphth 01234355122 ext 01234 anant.sharma@bedfordhospital.nhs.uk
Contact: Rynda Nitiahpapand, MBBS 01234355122 ext 01234 rynda.nitiahpapand@bedfordhospital.nhs.uk

Sponsors and Collaborators
Bedford Hospital NHS Trust
Investigators
Layout table for investigator information
Principal Investigator: Anant Sharma, MBBS, FRCOphth Bedford Hospital Moorfields Eye Unit
Publications:

Layout table for additonal information
Responsible Party: Anant Sharma, Consultant Ophthalmic Surgeon, Bedford Hospital NHS Trust
ClinicalTrials.gov Identifier: NCT03500809    
Other Study ID Numbers: IRAS 240539
First Posted: April 18, 2018    Key Record Dates
Last Update Posted: July 27, 2018
Last Verified: July 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Cataract
Postoperative Complications
Lens Diseases
Eye Diseases
Pathologic Processes